Financial reports
10-K
2023 FY
Annual report
28 Feb 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
27 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
10-K
2021 FY
Annual report
24 Feb 22
Current reports
8-K
CareDx Appoints John W. Hanna as its New President and Chief Executive Officer
16 Apr 24
8-K
CareDx Appoints Bryan Riggsbee to Its Board of Directors
11 Mar 24
8-K
CareDx Announces Fourth Quarter and Full Year 2023 Financial Results
28 Feb 24
8-K
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2023
9 Jan 24
8-K
Departure of Directors or Certain Officers
22 Dec 23
8-K
CareDx Reports Third Quarter 2023 Results
8 Nov 23
8-K
CareDx Announces CEO Transition
1 Nov 23
8-K
Departure of Directors or Certain Officers
26 Sep 23
8-K
Other Events
25 Sep 23
8-K
CareDx Reports Second Quarter 2023 Results
8 Aug 23
Registration and prospectus
POS AM
Prospectus update (post-effective amendment)
1 Mar 24
POSASR
Automatic shelf registration (post-effective amendment)
28 Feb 24
S-8
Registration of securities for employees
12 Jan 24
S-3ASR
Automatic shelf registration
10 May 23
S-8
Registration of securities for employees
27 Feb 23
424B5
Prospectus supplement for primary offering
14 Apr 22
S-8
Registration of securities for employees
13 Apr 22
S-8
Registration of securities for employees
6 Aug 21
424B5
Prospectus supplement for primary offering
21 Jan 21
424B5
Prospectus supplement for primary offering
19 Jan 21
Proxies
DEFA14A
Additional proxy soliciting materials
1 May 23
DEF 14A
Definitive proxy
28 Apr 23
PRE 14A
Preliminary proxy
14 Apr 23
DEFA14A
Additional proxy soliciting materials
2 May 22
DEF 14A
Definitive proxy
2 May 22
DEFA14A
Additional proxy soliciting materials
30 Apr 21
DEF 14A
Definitive proxy
30 Apr 21
PRE 14A
Preliminary proxy
28 Apr 21
DEF 14A
Definitive proxy
20 Apr 21
DEFA14A
Additional proxy soliciting materials
8 Jun 20
Other
CT ORDER
Confidential treatment order
22 Dec 21
UPLOAD
Letter from SEC
1 Sep 20
CORRESP
Correspondence with SEC
26 Aug 20
UPLOAD
Letter from SEC
5 Aug 20
CT ORDER
Confidential treatment order
16 Jul 19
CT ORDER
Confidential treatment order
4 Feb 19
EFFECT
Notice of effectiveness
12 Oct 18
CORRESP
Correspondence with SEC
10 Oct 18
CT ORDER
Confidential treatment order
10 Oct 18
EFFECT
Notice of effectiveness
8 Dec 17
Ownership
4
Abhishek Jain
10 Apr 24
4/A
Abhishek Jain
9 Apr 24
4/A
Alexander L Johnson
9 Apr 24
4
Peter Maag
8 Apr 24
4
Michael Goldberg
8 Apr 24
SC 13G/A
ArrowMark Colorado Holdings LLC
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
GAGNON SECURITIES LLC
13 Feb 24
SC 13G/A
Bellevue Asset Management (UK) Ltd.
13 Feb 24
SC 13G
Nikko Asset Management Americas, Inc.
12 Feb 24